New stroke drug candidate passes first safety check in healthy people

This early-stage study tested the safety and tolerability of a new drug called HRS-8829 in 83 healthy adults aged 18 to 55. The drug is being developed for acute ischemic stroke. Participants received either the drug or a placebo, and researchers monitored side effects and how the drug moved through the body. The goal was to gather safety information, not to treat any disease.